-
Global priorities for advancing cancer survivorshi
Author: Wong, Henry C. Y.; Hart, Nicolas H.; Chan, Alexandre; Ee, Carolyn; Thamm, Carla; Chan, Raymond J
Journal: CURRENT OPINION IN ONCOLOGY. 2026; Vol. 38, Issue 2, pp. 137-145. DOI: 10.1097/CCO.0000000000001217
-
Artificial intelligence in lung cancer: from diagnosis to therap
Author: Wang, Yongsheng; Miao, Liyun; Zhou, Caicun
Journal: CURRENT OPINION IN ONCOLOGY. 2026; Vol. 38, Issue 1, pp. 83-88. DOI: 10.1097/CCO.0000000000001199
-
Systemic therapy of nonsmall cell lung cancer: breakthroughs during the last five decade
Author: Pirker, Robert; Zhou, Caicun
Journal: CURRENT OPINION IN ONCOLOGY. 2026; Vol. 38, Issue 1, pp. 25-30. DOI: 10.1097/CCO.0000000000001201
-
The evolving landscape of bispecific antibodies in the treatment of lung cance
Author: Jin, Xuanhong; Chang, Chang; Zhou, Fei
Journal: CURRENT OPINION IN ONCOLOGY. 2026; Vol. 38, Issue 1, pp. 54-70. DOI: 10.1097/CCO.0000000000001206
-
Antibody-drug conjugates in lung cancer: current landscape and future perspective
Author: Chen, Xinru; Zhou, Caicun
Journal: CURRENT OPINION IN ONCOLOGY. 2026; Vol. 38, Issue 1, pp. 71-82. DOI: 10.1097/CCO.0000000000001200
-
MDM2 inhibitors in sarcomas: results and next step
Author: Tortorelli, Ilaria; Napolitano, Andrea; Zhou, Yuhong; Huang, Paul; Jones, Robin L
Journal: CURRENT OPINION IN ONCOLOGY. 2025; Vol. 37, Issue 4, pp. 324-330. DOI: 10.1097/CCO.0000000000001146
-
Recent advances in immunotherapy for small cell lung cance
Author: Ren, Ziyuan; Shang, Shijie; Chen, Dawei
Journal: CURRENT OPINION IN ONCOLOGY. 2025; Vol. 37, Issue 1, pp. 17-26. DOI: 10.1097/CCO.0000000000001107
-
Perioperative immunotherapy for nonsmall cell lung cance
Author: Huang, Jingya; Li, Wenyuan; Guo, Hui
Journal: CURRENT OPINION IN ONCOLOGY. 2025; Vol. 37, Issue 1, pp. 63-72. DOI: 10.1097/CCO.0000000000001106
